Tigecycline for injection
Indication
Tigecycline is approved for the treatment of complicated skin and skin structure infections or complicated intra-abdominal infections in patients 18 years of age and older, including complicated appendicitis, burn infections, intra-abdominal abscesses, deep soft tissue infections, and ulcer infections.
Packaging Specification
50mg
Manufacturer
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
-
Founded in:
1995-07-26 -
Address:
Lianyungang Economic and Technological Development Zone, Jiangsu Province -
Tax NO.:
913207006083959289 -
Registered Funds:
1,000,000,000 Yuan -
Website:
-
Email: